Search

everythinglearnresearchcommunity

for

Search:↓

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Skin inflammation can worsen intestinal inflammation and colitis.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Inflammation is a key factor in heart disease and targeting it can reduce heart problems.

TNF-alpha inhibitors can cause various immune-related skin issues.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Infliximab may cause hair loss in Crohn's disease patients.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Anti-TNF therapy can cause hair loss and skin issues.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

PRP injections may improve hair loss condition, but more research needed.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Some drugs for inflammation may cause psoriasis-like hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.